Pro Share Advisors LLC Spectrum Pharmaceuticals Inc Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$0.43 - $1.56 $774 - $2,809	1,801 Added 12.84%	15,826 $7,000
Q2 2022 Aug 01, 2022	SELL	$0.7 - $1.4 $23,459 - $46,918	-33,513 Reduced 70.5%	14,025 $11,000
Q1 2022 May 10, 2022	SELL	$0.63 - $1.59 $10,273 - $25,928	-16,307 Reduced 25.54%	47,538 $61,000
Q4 2021 Feb 08, 2022	BUY	$1.27 - $2.42 $4,659 - $8,878	3,669 Added 6.1%	63,845 $81,000
Q3 2021 Nov 12, 2021	SELL	$2.15 - $3.82 $28,850 - $51,260	-13,419 Reduced 18.23%	60,176 $131,000
Q2 2021 Aug 13, 2021	BUY	$2.89 - $4.45 $30,486 - $46,943	10,549 Added 16.73%	73,595 $276,000
Q1 2021 May 14, 2021	BUY	$2.9 - $4.09 $16,741 - $23,611	5,773 Added 10.08%	63,046 $206,000
Q4 2020 Feb 09, 2021	BUY	$3.38 - $5.14 $45,548 - $69,266	13,476 Added 30.77%	57,273 $195,000
Q3 2020 Nov 13, 2020	BUY	$2.99 - $4.9 $22,709 - $37,215	7,595 Added 20.98%	43,797 $179,000
Q2 2020 Aug 03, 2020	BUY	$2.11 - $3.38 $25,917 - $41,516	12,283 Added 51.35%	36,202 $122,000
Q1 2020 May 15, 2020	SELL	$1.83 - $3.45 $34,275 - $64,618	-18,730 Reduced 43.92%	23,919 $56,000
Q4 2019 Feb 12, 2020	SELL	$3.5 - $10.35 $12,089 - $35,748	-3,454 Reduced 7.49%	42,649 $155,000
Q3 2019 Nov 12, 2019	SELL	$7.03 - $9.7 $2,200 - $3,036	-313 Reduced 0.67%	46,103 $382,000
Q2 2019 Aug 13, 2019	SELL	$7.36 - $11.26 $39,066 - $59,768	-5,308 Reduced 10.26%	46,416 $400,000
Q1 2019 May 15, 2019	BUY	$9.08 - $11.84 $18,377 - $23,964	2,024 Added 4.07%	51,724 $553,000
Q4 2018 Feb 14, 2019	SELL	$6.39 - $16.99 $53,298 - $141,713	-8,341 Reduced 14.37%	49,700 $435,000
Q3 2018 Nov 14, 2018	SELL	$16.52 - $24.82 $29,025 - $43,608	-1,757 Reduced 2.94%	58,041 $975,000
Q2 2018 Aug 13, 2018	SELL	$14.31 - $21.75 $9,415 - $14,311	-658 Reduced 1.09%	59,798 $1.25 Million
Q1 2018 May 14, 2018	SELL	$16.09 - $23.07 $151,696 - $217,503	-9,428 Reduced 13.49%	60,456 $973,000
Q4 2017 Feb 14, 2018	BUY	$13.36 - $20.73 $206,465 - $320,361	15,454 Added 28.39%	69,884 $1.32 Million
Q3 2017 Nov 13, 2017	BUY	$8.75 - $14.07 $45,666 - $73,431	5,219 Added 10.61%	54,430 $766,000
Q2 2017 Aug 11, 2017	BUY	N/A	49,211	49,211 $367,000

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account